Cost-Effectiveness Comparision Between aCGH 60K Platform and aCGH 180K Platform: Retrospective Analysis of Diagnostic Techniques for Neurodevelopmental Disorders and Congenital Malformations caused by a Genetic Alteration

Identifier:  TFG:9001

Handle: https://hdl.handle.net/20.500.11797/TFG9001

Authors:  Garrido Paco, Raquel

Abstract:
Demonstrate that the array CGH 60K platform presents the best rate cost-effective for the genetic diagnosis in patients with neurodevelopmental disorders. A retrospective analysis of the results from the array CGH technique 60K and 180K for prenatal and postnatal patients between 2016 and 2023 at the Hospital Universitari Sant Joan de Reus has been carried out. From all the 215 tests performed with the array CGH 180K, except of 2, could have been done with the array CGH 60K. The implantation of the array CGH 60K platform in the diagnosis of neurodevelopmental disorders supposes a benefit in terms of cost-effectiveness.